Navigation Links
Concerned Shareholders of Biovail Pleased with Court Order for Biovail AGM
Date:7/16/2008

TORONTO, July 16 /PRNewswire/ - Eugene Melnyk and EM Holdings B.V. (The "Concerned Shareholders") said today that they were pleased with the decision of the Ontario Superior Court of Justice released this morning. The Court denied the application brought by Biovail Corporation and its CEO, William Wells, for an order validating the election of the board of directors at the shareholder meeting convened on June 25, 2008. Further, the Court determined that the Biovail Annual General Meeting was improperly constituted and must be re-convened in order to allow for the election of directors at a meeting complying with corporate law and the company's by-laws.

"Biovail's AGM was not properly constituted and there was no quorum present, as the court recognized," stated Mr. Brydon. "Remember, a majority of shareholders did not cast their votes. This is a strong indication that shareholders are deeply frustrated with the status quo at Biovail. Today's court ruling means all shareholders will have an opportunity to further evaluate the two very different visions for the future of Biovail."

The Court ordered that the Annual General Meeting be re-convened as soon as reasonably possible, but in any event, by September 23, 2008.

Mr. Melnyk and Mr. Brydon are so confident in the strength of the plan proposed by the Concerned Shareholders that they will move it forward no matter what the outcome at Biovail's re-convened Annual General Meeting. The plan will either be implemented through Biovail, if the Concerned Shareholders' nominees are elected at the re-convened Annual General Meeting, or through a new company, Trimel Biopharma, that Eugene Melnyk and Bruce Brydon have already announced they will form if the Concerned Shareholders are unsuccessful at the re-convened Annual General Meeting. Mr. Brydon will be reaching out to Biovail shareholders during the coming weeks to further discuss this plan, the opportunity to support it and benefit from its success and the plan's ability to protect investment and enhance value for all Biovail shareholders.

In the coming days, the Concerned Shareholders encourage all shareholders to visit http://www.betterbiovail.com to meet the proposed board members and review the proposed plan that they believe will help secure the future of the Company. The plan consists of four components with two overarching themes: a commitment to excellence in corporate governance, and a commitment to enhance shareholder value.


'/>"/>
SOURCE Concerned Shareholders of Biovail
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Concerned Shareholders of Biovail seek court order declaring Biovail AGM illegally convened;
2. Biovail Concerned Shareholders Welcome Glass Lewis Evaluation
3. Biovail Concerned Shareholders Want Open Debate
4. Shareholders Approve All Matters Proposed by Cell Therapeutics, Inc. at Special Meeting in Lieu of Annual Meeting of Shareholders
5. Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Thursday, June 19, 2008
6. Bioheart, Inc. to Host Annual Meeting of Shareholders on Wednesday, July 30, 2008
7. Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
8. Medco CEO to Shareholders: Delivering Results, Driving Shareholder Value
9. Spherix Holds Annual Shareholders Meeting
10. WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders Meeting
11. Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report ... detail how a patient who developed lymphedema after being treated for breast cancer benefitted ... change the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory ... technical consulting, provides a free webinar on Performing Quality Investigations: Getting ... at 12pm CT at no charge. , Incomplete investigations are still a major ...
Breaking Biology Technology:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
Breaking Biology News(10 mins):